© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Bromhexine Hydrochloride serves a practical role in many cough and cold products, especially for those targeting thick mucus in the respiratory system. The material helps loosen and thin out secretions, making it easier for people to get relief from congestion. My time working alongside pharmacists has shown me just how frequently doctors turn to this compound when dealing with stubborn chest congestion in both kids and adults. Its active mechanism transforms viscous, sticky phlegm, easing breathing in a way most folks notice within a few days of proper use.
The nature of Bromhexine Hydrochloride makes it suitable for both pharmaceutical and chemical applications. It appears as a white to slightly yellowish crystalline powder, often presenting as odorless and having a noticeably bitter taste—something manufacturers work hard to mask in the finished tablet or syrup. What matters to a lot of us in formulation is the density and stability of the compound. The density measures close to 1.5 g/cm³, which has direct impact on how tablets are compressed and how suspensions are mixed. Its melting point ranges near 248 °C, emphasizing its stability at typical storage conditions. No strange volatility or reactivity surprises pop up, which has always made it less troublesome in the lab. The compound dissolves moderately in water, more so in alcohol and other organic solvents, gaining further flexibility for solution-based products.
Looking at molecules up close gives both the scientific and everyday world a better understanding of how medications work. Bromhexine Hydrochloride carries the molecular formula C14H20Br2N2·HCl and a molecular weight of about 412.56. Its structure features two bromine atoms, which play a key role in the compound’s expectorant properties. The raw material commonly enters the processing line in solid crystalline form, sometimes milled into a fine powder or shaped into small flakes and pearls depending on production needs. The material’s crystal form supports excellent purity, with typical specifications calling for a minimum purity of 98% as tested by HPLC methods.
Every bulk shipment and import needs the right code to move through customs smoothly. Bromhexine Hydrochloride falls under HS Code 2922199090 for international trade, making it identifiable to officials and industry alike. My experience in pharmaceutical supply chains tells me that getting this small detail wrong can lead to frustrating delays and extra costs, so getting the specifications right on the packing sheet can save days, sometimes weeks. Compliance with country-specific regulations, such as pharmacopoeia standards, is not optional—inspectors have a sharp eye for certificates and safety documents.
The pharmaceutical industry commonly works with Bromhexine Hydrochloride as a solid—powder, fine crystalline, or small pearl-like granules. The solid stays stable, stores well, and blends into formulations without causing unexpected chemical changes. In rare cases, research labs may use solution forms for precision in dosing or for developing new routes of administration. Handling the raw powder requires a controlled environment, as dust can be mildly irritating and its fine texture makes inhalation easy if basic controls are ignored. The material’s bulk density and particle size become critical where suspension syrups or dissolvable tablets are being made; these factors determine sedimentation rates and mouthfeel in the finished product.
Handling chemicals always demands respect and preparation, even with medicines most people trust. Bromhexine Hydrochloride does not rank among the most hazardous materials in the laboratory, but it brings some risks. Direct inhalation of powder, prolonged skin contact, or accidental ingestion by staff not following protocols can lead to irritation or mild toxic effects. My years working in pharmaceutical manufacturing taught me the value of good gloves, dust masks, and having a Material Safety Data Sheet (MSDS) on hand. Facilities storing this material need to keep it dry, shielded from direct sunlight, and away from acids or oxidizing agents. For spills, ordinary industrial vacuums do the trick, but always with proper filtration and containment to protect workers. The compound is not classified as highly flammable or explosive, so regular fire safety measures prove sufficient.
In production, Bromhexine Hydrochloride begins its journey as a raw material, brought in bulk quantities before conversion into a final product. Manufacturing tablets, syrups, or even oral drops all start with weighing and testing this crystalline compound. A manufacturer interested in producing liquid solutions will focus on proper solvent ratios and dissolution rates, since incomplete mixing gives gritty, unpleasant products that consumers reject. For solid dosage forms, accuracy in powder mixing assures even distribution of the active molecule, avoiding batch failures or unpredictable dosing. My interactions with QA specialists highlight that attention to the starting ingredient stops dozens of downstream quality complaints.
What stands out with Bromhexine Hydrochloride, from a long-term view, is its enduring reliability and versatility as a respiratory aid. Generics and branded options alike depend on predictable chemical and physical properties. Adulteration or subpar batches threaten both patient outcomes and business reputations, so continuous analytical testing is never a wasted effort. As health authorities tighten controls on active pharmaceutical ingredients worldwide, the industry’s focus shifts more often to transparent sourcing, strong documentation, and verifiable origin. Cost pressure never disappears, yet the price of cutting corners is usually higher in the end. With evolving regulatory standards and growing demand for respiratory care—especially after pandemic lessons—manufacturers who emphasize secure sourcing, responsible handling, and detailed chemical control will stay ahead.
